Work

Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

Year: 2010
Type: article
Author: The Executive Steering Committee, on behalf of the ROCKET AF Study Investigators
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W3388698
FWCI: 53.3
Cites: 40
Cited by: 479
Related to: 10